 |
Mitoxantrone hydrochloride liposome |
|---|---|
| Trade Name | |
| Orphan Indication | T-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-09-20 00:00:00 |
| Sponsor | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.;., a subsidiary company within CSPC Pharmaceutical Group, Ltd, 226 Huanghe Avenue;Shijiazhuang Shi |
